DRAK2 suppresses autophagy by phosphorylating ULK1 at Ser 56 to diminish pancreatic β cell function upon overnutrition

Yuting Lu,Junyu Xu,Yufeng Li,Ruoran Wang,Chengqiu Dai,Bingqian Zhang,Xinwen Zhang,Lei Xu,Yunhua Tao,Ming Han,Ren Guo,Qingqian Wu,Linshi Wu,Zhuoxian Meng,Minjia Tan,Jingya Li
DOI: https://doi.org/10.1126/scitranslmed.ade8647
IF: 17.1
2024-02-08
Science Translational Medicine
Abstract:Impeded autophagy can impair pancreatic β cell function by causing apoptosis, of which DAP-related apoptosis-inducing kinase-2 (DRAK2) is a critical regulator. Here, we identified a marked up-regulation of DRAK2 in pancreatic tissue across humans, macaques, and mice with type 2 diabetes (T2D). Further studies in mice showed that conditional knockout (cKO) of DRAK2 in pancreatic β cells protected β cell function against high-fat diet feeding along with sustained autophagy and mitochondrial function. Phosphoproteome analysis in isolated mouse primary islets revealed that DRAK2 directly phosphorylated unc-51–like autophagy activating kinase 1 (ULK1) at Ser 56 , which was subsequently found to induce ULK1 ubiquitylation and suppress autophagy. ULK1-S56A mutation or pharmacological inhibition of DRAK2 preserved mitochondrial function and insulin secretion against lipotoxicity in mouse primary islets, Min6 cells, or INS-1E cells. In conclusion, these findings together indicate an indispensable role of the DRAK2-ULK1 axis in pancreatic β cells upon metabolic challenge, which offers a potential target to protect β cell function in T2D.
cell biology,medicine, research & experimental
What problem does this paper attempt to address?